By blocking cell division, chemotherapy drugs take advantage of the fact that cancer cells multiply rapidly in the body. Though this treatment can extend and even save the lives of cancer patients, it’s somewhat like destroying an ant hill with an atomic bomb: there’s a lot of collateral damage. The treatment is infused through the … Continue reading UC Irvine scientists engineer stem cells to “feel” cancer and destroy it
Disease Areas
CIRM-funded life-saving stem cell therapy gets nod of approval from FDA
If you have read our 2016 Annual Report (and if you haven’t you should, it’s brilliant) or just seen the cover you’ll know that it features very prominently a young girl named Evie Padilla Vaccaro. Evie was born with Severe Combined Immunodeficiency or SCID – also known as “bubble baby disease”; we’ve written about it … Continue reading CIRM-funded life-saving stem cell therapy gets nod of approval from FDA
Stem cell agency funds Phase 3 clinical trial for Lou Gehrig’s disease
At CIRM we don’t have a disease hierarchy list that we use to guide where our funding goes. We don’t rank a disease by how many people suffer from it, if it affects children or adults, or how painful it is. But if we did have that kind of hierarchy you can be sure that … Continue reading Stem cell agency funds Phase 3 clinical trial for Lou Gehrig’s disease
Novel diabetes therapy uses stem cell “teachers” to calm immune cells
Type 1 diabetes is marked by a loss of insulin-producing beta cells in the pancreas. Without insulin, blood sugar can’t shuttle into the body’s energy-hungry organs and tissues. As a result, sugar accumulates in the blood which, over time, causes many serious complications such as kidney disease, heart disease and stroke. An over-reactive immune system … Continue reading Novel diabetes therapy uses stem cell “teachers” to calm immune cells
Stories that caught our eye: Spinal cord injury trial milestone, iPS for early cancer diagnosis, and storing videos in DNA
Spinal cord injury clinical trial hits another milestone (Kevin McCormack) We began the week with good news about our CIRM-funded clinical trial with Asterias for spinal cord injury, and so it’s nice to end the week with more good news from that same trial. On Wednesday, Asterias announced it had completed enrolling and dosing patients … Continue reading Stories that caught our eye: Spinal cord injury trial milestone, iPS for early cancer diagnosis, and storing videos in DNA
One man’s journey with leukemia has turned into a quest to make bone marrow stem cell transplants safer
I read a story yesterday in Science Magazine that really stuck with me. It’s about a man who was diagnosed with leukemia and received a life-saving stem cell transplant that is now threatening his health. The man is name Lukas Wartman and is a doctor at Washington University School of Medicine in St. Louis. He … Continue reading One man’s journey with leukemia has turned into a quest to make bone marrow stem cell transplants safer
Harnessing DNA as a programmable instruction kit for stem cell function
DNA is the fundamental molecule to all living things. The genetic sequences embedded in its double-helical structure contain the instructions for producing proteins, the building blocks of our cells. When our cells divide, DNA readily unzips into two strands and makes a copy of itself for each new daughter cell. In a Nature Communications report … Continue reading Harnessing DNA as a programmable instruction kit for stem cell function
One day, scientists could grow the human cardiovascular system from stem cells
The human cardiovascular system is an intricate, complex network of blood vessels that include arteries, capillaries and veins. These structures distribute blood from the heart to all parts of the body, from our head to our toes, and back again. This week, two groups of scientists published studies showing that they can create key components … Continue reading One day, scientists could grow the human cardiovascular system from stem cells
CIRM-funded stem cell clinical trial for spinal cord injury expands patient recruitment
It’s always great to start the week off with some good news. Today we learned that the Food and Drug Administration (FDA) has given Asterias Biotherapeutics approval to expand the number and type of people with spinal cord injuries that it treats in their CIRM-funded clinical trial. Up till now, Asterias has been treating people … Continue reading CIRM-funded stem cell clinical trial for spinal cord injury expands patient recruitment
Stories that caught our eye: smelling weight gain, colon cancer & diet and diabetes & broken bones
How smelling your food could cause weight gain (Karen Ring). Here’s the headline that caught my eye this week: “Smelling your food first can make you fat…” It’s a bizarre statement, but the claim is backed by scientific research coming from a new study in Cell Metabolism by researchers at the University of California Berkeley. … Continue reading Stories that caught our eye: smelling weight gain, colon cancer & diet and diabetes & broken bones
The Stem Cellar 